Chemical identity

16beta-Hydroxystanozolol

CAS 125590-76-3 · C21H32N2O2

01Identity

Identifiers and names for this exact compound. Empty fields are left unassigned.

Lazychem IDLC-04219
PubChem CID14299609
Name16beta-Hydroxystanozolol
CAS RN125590-76-3
Molecular formulaC21H32N2O2
Molecular weight344.5 g/mol
IUPAC name(1R,2S,3aS,3bR,5aS,10aS,10bS,12aS)-1,10a,12a-Trimethyl-1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydrocyclopenta[5,6]naphtho[1,2-f]indazole-1,2-diol; (5α,16β,17β)-17-Μethyl-2'H-αndrost-2-eno[3,2-c]pyrazole-16,17-diol
InChIKeyIZGBPAAEPVNBGA-BWPSUJIGSA-N

02Structure identifiers

2D structure: 16beta-Hydroxystanozolol, CAS 125590-76-3
Structure of 16beta-Hydroxystanozolol (CAS 125590-76-3). LazyChem record. Source identity: PubChem CID 14299609. Confirm the identifiers before analytical use.Download structure image

Structure facts for this exact identity.

Molecular formulaC21H32N2O2
InChIKeyIZGBPAAEPVNBGA-BWPSUJIGSA-N
Ring count5
Defined stereocentres8
Unassigned stereocentres0
SMILESC[C@]12CC[C@H]3[C@H]([C@@H]1C[C@@H]([C@]2(C)O)O)CC[C@@H]4[C@@]3(CC5=C(C4)NN=C5)C
InChIInChI=1S/C21H32N2O2/c1-19-10-12-11-22-23-17(12)8-13(19)4-5-14-15(19)6-7-20(2)16(14)9-18(24)21(20,3)25/h11,13-16,18,24-25H,4-10H2,1-3H3,(H,22,23)/t13-,14+,15-,16-,18-,19-,20-,21-/m0/s1

03Stereochemistry

The published structure contains 8 defined and 0 unassigned tetrahedral stereocentres. The exact wedge-and-dash depiction is shown above.

Defined stereocentres82D structure
Unassigned stereocentres02D structure
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 256Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04India status for this compound

These results apply only to this exact compound name and CAS number. Confirm the current official instruments before making a regulatory decision.

NDPS / RCSNOT FOUND IN REVIEWED ENTRIESCAS 125590-76-3 was not found in the reviewed exact-identity entries. Generic, class, analogue, salt and isomer provisions were not evaluated.
SCOMETNOT FOUND IN REVIEWED CAS ENTRIESCAS 125590-76-3 was not found in the reviewed exact-CAS mapping. Generic and analogue entries were not evaluated.

05Names and relationships

Associated parent compound

Stanozolol

View API and impurity family

Other names

  • Cyclopenta[7, 8]phenanthro[2, 3-c]pyrazole, 2'H-androst-2-eno[3, 2-c]pyrazole-16, 17-diol deriv.

06Documented history

Dated discovery, occurrence, use and issue claims are published only when a suitable primary or government source is available.

No dated history available

No verified discovery, first report, occurrence, use or issue event is currently available for this identity.

07Sources